Source comparison
Combine BPC-157 CJC-1295: Research Protocol Comparison
VEGF Upregulation Timeline Peaks 3–6 hours post-dose; localized to injection proximity No direct VEGF effect; IGF-1-mediated angiogenesis occurs systemically over days BPC establishes vascular infrastructure before GH pulse; VEGF peaks align with early IGF-1 e
This comparison does not assign a generated winner or score.
- VEGF Upregulation Timeline
- Peaks 3–6 hours post-dose; localized to injection proximity
- No direct VEGF effect; IGF-1-mediated angiogenesis occurs systemically over days
- BPC establishes vascular infrastructure before GH pulse; VEGF peaks align with early IGF-1 elevation
- VEGF and GH pulses occur simultaneously; no temporal coordination of anabolic signaling
- Staggered protocol allows BPC-157's angiogenic priming to precede CJC-1295's systemic anabolic drive
- IGF-1 Kinetics
- No direct IGF-1 stimulation; tissue repair is IGF-1-independent
- IGF-1 elevation begins 6–12h post-dose, peaks 24–48h, remains elevated 6–8 days
- IGF-1 rise occurs after BPC-157 has primed tissue; localized delivery enhanced by improved vascularity
- IGF-1 elevation occurs without prior vascular optimization; systemic effect not matched by local readiness
- Staggered timing ensures IGF-1 delivery infrastructure is established before peak systemic levels
- Recommended Dosing Frequency
- 250–500 mcg SC twice daily
- 1–2 mg SC once weekly
- BPC 250–500 mcg twice daily; CJC 1–2 mg once weekly, 4–6h after morning BPC dose
- BPC + CJC administered same time, risking albumin competition and suboptimal timing
- Frequency should match each peptide's half-life; timing separation avoids receptor competition
- Injection Site Considerations
- Rotate periumbilical, thigh, deltoid sites; localized tissue effect favors proximity to injury
- Deeper SC in high-adipose areas (abdomen, glutes); systemic effect site-independent
- Separate sites for each peptide; BPC near target tissue, CJC in high-adipose depot
- Single-site administration acceptable but offers no kinetic advantage
- Site separation prevents depot overlap and allows independent absorption kinetics
- Reconstitution Stability
- Stable 60–90 days at 2–8°C post-reconstitution
- Stable ~28 days at 2–8°C post-reconstitution
- Stagger reconstitution dates; prepare CJC weekly, BPC in 2–3 week batches
- Both vials expire on same timeline; increases waste if CJC degrades faster
- Match reconstitution volume to usage timeline; CJC's shorter stability demands smaller batch prep